Cytosponge Protocol IRB 11-006429



Status:Recruiting
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 65
Updated:2/3/2019
Start Date:December 2012
End Date:September 2019
Contact:Debra M. Geno, CCRP
Email:geno.debra@mayo.edu
Phone:507-538-0367

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Cytosponge Protocol

Whether the cytosponge will be a useful non-invasive tool in evaluating patients with
eosinophilic esophagitis?


Inclusion Criteria:

•Adult patients between the ages of 18 and 65 with eosinophilic esophagitis including
lactating or pregnant women undergoing clinically indicated endoscopy and esophageal
biopsy.

Exclusion Criteria:

- Patients for whom clinically indicated endoscopy is not safe. Patients who have small
caliber esophagus, an esophageal stricture that will not permit passage of the gelatin
capsule or are unable to swallow the capsule.

- Vulnerable populations, such as those with diminished mental acuity, will be excluded.

- Patients with known Lidocaine/Acetylcysteine allergies
We found this trial at
1
site
Mayo Clinic Rochester
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: David Katzka, M.D.
Phone: 507-538-0367
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials